Showing 25–36 of 61 results
-
CALBRICK D3 Sachets
Background
CALBRICK-D3 is a high-strength Vitamin D₃ (Cholecalciferol) supplement delivering 60,000 IU per sachet. As a crucial fat-soluble vitamin, it supports calcium and phosphorus absorption, promotes bone mineralization, regulates immune response, and maintains metabolic balance.
Formulated as granulated sachets, CALBRICK-D3 ensures easy weekly dosing, excellent patient compliance, and effective management of Vitamin D deficiency.
-
CALBRICK MAX
CLINICAL BENEFITS:
- Benfotiamine:
➤ Reduces formation of Advanced Glycation End-products (AGEs)
➤ Lowers oxidative stress to protect nerve function - Alpha Lipoic Acid (ALA):
➤ Powerful antioxidant
➤ Stimulates Nerve Growth Factor (NGF)
➤ Promotes axonal regeneration - Methylcobalamin (MCBM):
➤ Essential for myelin sheath synthesis and repair
➤ Enhances nerve conduction
- Benfotiamine:
-
CALBRICK PLUS
✅ CALBRICK PLUS
Composition:
- Calcitriol 0.25 mcg
- Calcium Carbonate 500 mg
- DHA (Docosahexaenoic Acid) 120 mg
- EPA (Eicosapentaenoic Acid) 180 mg
- Elemental Boron 1.5 mg
- Folic Acid 400 mcg
- Methylcobalamin 1500 mcg
-
CALBRICK PRO
Background:
- Calcitriol
Enhances intestinal calcium absorption and renal reabsorption, supporting blood calcium levels and bone mineralization. - Calcium Carbonate
Essential for bone strength; helps reduce fracture risk by preventing calcium deficiency. - EPA & DHA (Omega-3 Fatty Acids)
Modulate inflammatory pathways, reduce osteoclast activity, and promote osteoblast function—crucial for bone remodeling. - Boron
A trace mineral that helps maintain calcium, magnesium, and phosphorus levels in bones. - Folic Acid & Methylcobalamin (Vitamin B12)
Work together to reduce homocysteine levels, minimizing the risk of bone weakening and fractures. - Note: Zinc depletion can reduce the body’s response to calcitriol therapy.
- Calcitriol
-
CELLI Q TEN GOLD
DESCRIPTION:
CELLI Q-TEN GOLD is a specially formulated tablet containing Coenzyme Q10, L-Carnitine, Lycopene, L- Arginine, Selenium, zinc & Folic acid. It is designed for use in deficiency states and medical conditions including:
- Cardiovascular disease
- Neuromuscular disorders
- Hypertension
- Periodontal disease
- Hyperthyroidism
- Male infertility
- AIDS
-
CELLI Q-10
Description:
Celli Q 10 is a scientifically developed formulation designed to support respiratory health in patients with asthma and Chronic Obstructive Pulmonary Disease (COPD). Both conditions are associated with oxidative stress and REDOX imbalance. Celli Q 10 combines potent antioxidants and nutrients to help restore balance and enhance respiratory function.
-
ESOBRICK 40
Rated 5.00 out of 5Background
Gastroesophageal Reflux Disease (GERD) and Functional Dyspepsia are highly prevalent gastrointestinal disorders worldwide. These conditions often coexist, making clinical differentiation difficult.
- The global prevalence of GERD is around 99%, and Functional Dyspepsia affects 20–30% of the general population.
- Proton Pump Inhibitors (PPIs), alone or combined with prokinetic agents, are proven effective in relieving symptoms and improving quality of life in acid-related disorders.
-
ESOBRICK-D
Background
Gastroesophageal Reflux Disease (GERD) and Functional Dyspepsia are highly prevalent gastrointestinal disorders worldwide. These conditions often coexist, making clinical differentiation difficult.
- The global prevalence of GERD is around 99%, and Functional Dyspepsia affects 20–30% of the general population.
- Proton Pump Inhibitors (PPIs), alone or combined with prokinetic agents, are proven effective in relieving symptoms and improving quality of life in acid-related disorders.
-
ESOBRICK-IT
Background
Gastroesophageal Reflux Disease (GERD) and Functional Dyspepsia are highly prevalent gastrointestinal disorders worldwide. These conditions often coexist, making clinical differentiation difficult.
- The global prevalence of GERD is around 99%, and Functional Dyspepsia affects 20–30% of the general population.
- Proton Pump Inhibitors (PPIs), alone or combined with prokinetic agents, are proven effective in relieving symptoms and improving quality of life in acid-related disorders.
-
ESOBRICK-L
Background
Gastroesophageal Reflux Disease (GERD) and Functional Dyspepsia are highly prevalent gastrointestinal disorders worldwide. These conditions often coexist, making clinical differentiation difficult.
- The global prevalence of GERD is around 99%, and Functional Dyspepsia affects 20–30% of the general population.
- Proton Pump Inhibitors (PPIs), alone or combined with prokinetic agents, are proven effective in relieving symptoms and improving quality of life in acid-related disorders.
-
FLAXMOX CV
Background:
The combination Amoxicillin + Clavulanic Acid + Lactic Acid Bacillus is a triple formulation that includes two drug components and one probiotic. Here’s a clear breakdown
a) Amoxicillin
A broad-spectrum penicillin-type (β-lactam) antibiotic.
It works by inhibiting bacterial cell wall synthesis, leading to bacterial death.
Active against many Gram-positive and some Gram-negative bacteria.
b) Clavulanic Acid
A β-lactamase inhibitor (similar role to tazobactam).
It prevents bacterial enzymes (β-lactamases) from destroying amoxicillin, making the antibiotic more effective against resistant strains.
c) Lactic Acid Bacillus
A probiotic (friendly bacteria) added to prevent or reduce antibiotic-associated diarrhea and restore the natural gut flora disturbed by antibiotics.

